Related Experiment Video

Updated: Aug 9, 2026

A Method for Islet Transplantation to the Omentum in Mouse
06:25

A Method for Islet Transplantation to the Omentum in Mouse

Published on: January 7, 2019

[Diabetes and heart transplantation]

M Loebe1, K Ramasubbu, D J Hamilton

  • 1Direktor Lungentransplantation, Department of Surgery, Baylor College of Medicine, 6560 Fannin Suite 1860, Houston TX 77030, USA. mloebe@bcm.tmc.edu

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|April 7, 2006
PubMed

Insights

Diabetes in heart transplant recipients has comparable long-term outcomes to non-diabetic patients. Post-transplant diabetes, often temporary, requires careful management of immunosuppressive therapy for optimal glucose control.

Area of Science:

  • Cardiology
  • Endocrinology
  • Transplantation Medicine

Context:

  • Diabetes is common in end-stage heart failure patients awaiting transplantation.
  • Historically, diabetes was a contraindication for heart transplantation.
  • Current practices allow for successful transplantation in diabetic patients.

Purpose:

  • To evaluate the outcomes of heart transplantation in diabetic patients.
  • To identify risk factors and characteristics of post-transplant diabetes.
  • To inform management strategies for glucose intolerance in heart transplant recipients.

Summary:

  • Diabetic patients achieve long-term outcomes comparable to non-diabetic recipients after heart transplantation with careful management.
  • Approximately one-third of heart transplant recipients develop post-transplant diabetes, often transient.
  • Diabetes does not significantly impact rejection rates, malignancies, or transplant vasculopathy.

Impact:

  • Individualized preoperative assessment and postoperative medication are crucial for successful outcomes.
  • Awareness of medication impact on glucose metabolism is vital for immunosuppressive therapy planning.
  • Multidisciplinary team management ensures effective monitoring and treatment of diabetes post-transplant.

More Related Videos

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...